Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Junio 23, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act.  Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to reapply for authorization to prescribe Schedule II controlled substances until April 30, 2024.  The settlement was announced by Michael F. Easley, Jr., United States Attorney for the Eastern District of North Carolina.

Based on its investigation, the United States contended that from approximately 2009 until 2018, Dr. Armitage issued prescriptions for opioids and other controlled substances outside the usual course of professional practice and not for a legitimate medical purpose.  For example, Dr. Armitage allegedly wrote prescriptions for “The Trinity”—the combination of an opioid, a benzodiazepine, and a muscle relaxer, which is frequently sought by drug abusers—on nearly 400 separate occasions between 2016 and 2018.  In total, Dr. Armitage allegedly wrote nearly 9,000 prescriptions for Schedule II controlled substances, like oxycodone, over that two-year time-period. 

The United States’ investigation followed a 2018 Consent Order entered by the North Carolina Medical Board, in which Dr. Armitage acknowledged that his multi-year prescribing of opioids and other controlled substance to one patient, who was a mother of four, “constitute[d] a departure from or a failure to conform to the standards of acceptable and prevailing medical practice.”  Dr. Armitage continued to prescribe the patient opioids and other controlled substances even after the patient exhibited numerous warnings signs of abuse, experienced significant weight loss, and went into acute narcotic withdrawal.  The patient was ultimately involuntarily admitted for addiction detoxification.

“Doctors take an oath to, first, do no harm.  Anything else is unacceptable, especially when it comes to prescribing opioids and other dangerous drugs.  Irresponsible doctors endanger their patients’ lives and can put a tremendous toll on society at large,” said United States Attorney Michael F. Easley, Jr.  “This case is just one part of our continued commitment to combat the opioid crisis by holding doctors accountable for compliance with the Controlled Substances Act.”

The resolution obtained in this matter was the result of a coordinated effort between the United States Attorney’s Office for the Eastern District of North Carolina and the Drug Enforcement Administration, Diversion Control Program.  Assistant United States Attorneys Michael Anderson and Andrew Kasper represented the United States.

The United States’ factual and legal assertions are allegations only, and there has been no admission or judicial determination of liability.  The civil settlement agreement is not an admission of any liability by Dr. Armitage, nor a concession by the United States that its potential claims were not well-founded.

The DEA encourages parents, along with their children, to educate themselves about the dangers of legal and illegal drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com, www.GetSmartAboutDrugs.com, www.CampusDrugPrevention.gov, and www.dea.gov . Also follow DEA Atlanta via Twitter at @DEAATLANTADiv

 

                                            ###

Download Press Release
###
Opioids
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jae W. Chung, Acting Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster